Dr Helen McKenna presented the initial findings of the TIMELORD study, on behalf of the MitOx team, as one of five finalists selected for the Intensive Care Foundation Research Gold Medal competition.
This competition is held annually at the State of the Art Meeting, and the Gold Medal is awarded to the new investigator who has shown excellence in science relevant to intensive care practice.
Team MitOx attended in support: Professor Monty Mythen, Dr Dan Martin, Helder Filipe and Margaret McNeil.
Translational MitOx Lab 